Today we confirmed the appointment of our latest partner hires as part of our expansion plans to open in Ireland.
The firm welcomes two new partners to open Taylor Wessing Ireland* with the support of UK partners James Goold and Alison Dennis.
Adam Griffiths, who was previously a member of the firm's private equity group and relocated to Ireland in 2017, has returned to Taylor Wessing to lead operations in Dublin.
Click here to view the July edition of Dates for Your Diary
Alderley Park, Cheshire – Infex Therapeutics is pressing ahead with a major development of its pandemic resilience strategy by today announcing an agreement with CRUK Newcastle Drug Discovery Unit. This will in-licence a novel therapy designed to treat SARS-CoV-2 along with future variants and a broad spectrum of coronaviruses.
The program, PAN-X, is an early stage drug that has shown encouraging activity during in-vitro testing.
AMSBIO has launched a new range of research grade biosimilars that enable analysis of biological processes without the need to purchase expensive therapeutic-grade biologics.
Metrion Biosciences appoints Nick Foster as Chief Commercial Officer and Head of Global Business Development
Appointment supports international growth within ion channel contract research and drug discovery
Reading Scientific Services Ltd (RSSL) has enhanced its Investigative and Quality Control (QC) capabilities with the installation of a new 600 MHz Bruker AVANCE NEO Nuclear Magnetic Resonance (NMR) spectrometer at its UK laboratories. The investment not only increases the scientific consultancy’s capacity to develop tailored analytical solutions, it also paves the way for further investigations into new NMR applications for the Life Science sectors.